AVE 16.7% 0.3¢ avecho biotechnology limited

Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-45

  1. 4,272 Posts.
    lightbulb Created with Sketch. 8299
    very sharp observation

    now combine that revelation with the following set of facts:

    Insomnia and anxiety are direct response actions of the amygdala (flight or fight response based on emotional memory experience- otherwise known as conditioning)
    the amygdala is informed by and informs the hippocampus
    thought provocation from the hippocampus and corresponding flight or fight response from the amygdala loads the data bank that referees these two responses which goes by the name of the anterior cingulate.
    once processed and the response has begun the hippocampus transmits the process to the hypothalamus which tries to maintain the sympathetic nervous system in a state of balanced homeostasis .....especislly critical during the sleep cycles.

    those with anxiety and chronic insomnia experience excessive imbalance in the homeostatic condition

    CBD is not a sedative nor a stimulant - though some reporting states this...why?

    it does however modulate this limbic system allowing the hypothalamus to do its work properly which results in re- established sleep cycles calming the amygdala and the anterior cingulate.

    CBD will restore the system to balance as this trial will demonstrate - the umbers are on the money
    that is why

    the trial design is good as is the cohort size

    this stock may well be the best bet on the ASX for these reasons in this trial alone


 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $3.461K 1.175M

Buyers (Bids)

No. Vol. Price($)
65 101062608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20323507 8
View Market Depth
Last trade - 15.44pm 16/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.